Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAGLA | Q9Y4D2 | 4/20 | 0.47 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.47 |
| ▸ | CTSS | P25774 | 6/20 | 0.43 |
| ▸ | CTSL | P07711 | 5/20 | 0.43 |
| ▸ | CTSK | P43235 | 5/20 | 0.43 |
| ▸ | CTSB | P07858 | 4/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | CMA1 | P23946 | 2/20 | 0.42 |
| ▸ | PRSS8 | Q16651 | 2/20 | 0.42 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.41 |
| ▸ | RBP4 | P02753 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6466589 | 0.89 | DAGLA (0.56) | DAGLAFAAHCES1CTSSCTSL | |
| SCHEMBL6466909 | 0.89 | DAGLA (0.56) | DAGLAFAAHCES1CTSSCTSL | |
| SCHEMBL6466058 | 0.87 | FAAH (0.49) | DAGLAFAAHCES1CTSSCTSL | |
| SCHEMBL7049727 | 0.84 | CTSS (0.46) | DAGLAFAAHCES1CTSSCTSL | |
| SCHEMBL6465889 | 0.83 | DAGLA (0.52) | DAGLAFAAHCES1CTSSCTSL | |
| SCHEMBL6467441 | 0.81 | PTPN1 (0.45) | DAGLAFAAHCES1POLBGAA | |
| SCHEMBL6464884 | 0.81 | CTSS (0.49) | DAGLAFAAHCES1CTSSCTSL | |
| SCHEMBL6465141 | 0.80 | CTSS (0.48) | DAGLAFAAHCES1CTSSCTSL | |
| SCHEMBL6463419 | 0.80 | CTSS (0.48) | DAGLAFAAHCES1CTSSCTSL | |
| SCHEMBL6468629 | 0.80 | CTSS (0.48) | DAGLAFAAHCES1CTSSCTSL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1516877-A1 | Amine derivatives as protease inhibitors | AXYS PHARMACEUTICALS, INC. (US) | 2005-03-23 | — | — | EP | disclosed |